Jakob Lembke

Stock Analyst at SEB Enskilda

(n/a)
# 4,761
Out of 4,835 analysts
2
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Jakob Lembke

AddLife AB (publ)
Jun 29, 2026
Downgraded: Hold
Price Target: kr 180.00
Current: kr 158.40
Upside: +13.64%
Xvivo Perfusion AB (publ)
Jun 21, 2023
Initiated Coverage: Buy
Price Target: kr 410.00
Current: kr 250.40
Upside: n/a